Phase 2 Depression and Anxiety Trial, Recruiting (NCT07673380)

Phase 2 Depression and Anxiety Trial, Recruiting NCT07673380 Sponsor: Washington University School of Medicine Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT07673380 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a history of using opioids and/or stimulants (such as cocaine or amphetamines)
You identify as Black and/or African American
You are currently seeking treatment at a local substance use treatment center
You can read and speak English fluently
You live in the United States
You are 18 years of age or older at the time the study data is collected

Who may not be able to join:

You feel that a cognitive or thinking difficulty (such as memory or comprehension problems) would make it hard for you to take part in research activities (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07673380

Sponsor: Washington University School of Medicine

Phase: Phase 2

Status: Recruiting

Condition: Depression and Anxiety

More information: https://clinicaltrials.gov/study/NCT07673380

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a history of using opioids and/or stimulants (such as cocaine or amphetamines)
You identify as Black and/or African American
You are currently seeking treatment at a local substance use treatment center
You can read and speak English fluently
You live in the United States
You are 18 years of age or older at the time the study data is collected

Who may not be able to join:

You feel that a cognitive or thinking difficulty (such as memory or comprehension problems) would make it hard for you to take part in research activities (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Washington University School of Medicine

Registry

ClinicalTrials.gov

Start date

31 August 2025

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Abstinence/ Changes in Substance Use; Opioid use/ Stimulant use disorder symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov